163 related articles for article (PubMed ID: 28992104)
21. Gene Expression Studies on Human Trisomy 21 iPSCs and Neurons: Towards Mechanisms Underlying Down's Syndrome and Early Alzheimer's Disease-Like Pathologies.
Weick JP; Kang H; Bonadurer GF; Bhattacharyya A
Methods Mol Biol; 2016; 1303():247-65. PubMed ID: 26235072
[TBL] [Abstract][Full Text] [Related]
22. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
[TBL] [Abstract][Full Text] [Related]
23. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
Majolo F; Marinowic DR; Machado DC; Da Costa JC
J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
[TBL] [Abstract][Full Text] [Related]
24. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
25. Targeted proteomics for quantification of histone acetylation in Alzheimer's disease.
Zhang K; Schrag M; Crofton A; Trivedi R; Vinters H; Kirsch W
Proteomics; 2012 Apr; 12(8):1261-8. PubMed ID: 22577027
[TBL] [Abstract][Full Text] [Related]
26. Preparation of iPSCs for Targeted Proteomic Analysis.
Baud A; Heywood WE; Little D; Gissen P; Mills K
Methods Mol Biol; 2019; 1994():131-139. PubMed ID: 31124110
[TBL] [Abstract][Full Text] [Related]
27. Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer's disease.
Tokuoka SM; Kita Y; Shimizu T; Oda Y
PLoS One; 2019; 14(12):e0226073. PubMed ID: 31821352
[TBL] [Abstract][Full Text] [Related]
28. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
[TBL] [Abstract][Full Text] [Related]
29. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
[TBL] [Abstract][Full Text] [Related]
30. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
31. Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.
Choi YS; Choe LH; Lee KH
Expert Rev Proteomics; 2010 Dec; 7(6):919-29. PubMed ID: 21142892
[TBL] [Abstract][Full Text] [Related]
32. Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric Disorders.
Zuccoli GS; Martins-de-Souza D; Guest PC; Rehen SK; Nascimento JM
Adv Exp Med Biol; 2017; 974():279-287. PubMed ID: 28353247
[TBL] [Abstract][Full Text] [Related]
33. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.
Hölttä M; Minthon L; Hansson O; Holmén-Larsson J; Pike I; Ward M; Kuhn K; Rüetschi U; Zetterberg H; Blennow K; Gobom J
J Proteome Res; 2015 Feb; 14(2):654-63. PubMed ID: 25490617
[TBL] [Abstract][Full Text] [Related]
34. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
Young JE; Goldstein LSB
Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
[TBL] [Abstract][Full Text] [Related]
35. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of neurite extension using induced pluripotent stem cells derived from lissencephaly patients with TUBA1A missense mutations.
Bamba Y; Shofuda T; Kato M; Pooh RK; Tateishi Y; Takanashi J; Utsunomiya H; Sumida M; Kanematsu D; Suemizu H; Higuchi Y; Akamatsu W; Gallagher D; Miller FD; Yamasaki M; Kanemura Y; Okano H
Mol Brain; 2016 Jul; 9(1):70. PubMed ID: 27431206
[TBL] [Abstract][Full Text] [Related]
37. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.
Kondo T; Asai M; Tsukita K; Kutoku Y; Ohsawa Y; Sunada Y; Imamura K; Egawa N; Yahata N; Okita K; Takahashi K; Asaka I; Aoi T; Watanabe A; Watanabe K; Kadoya C; Nakano R; Watanabe D; Maruyama K; Hori O; Hibino S; Choshi T; Nakahata T; Hioki H; Kaneko T; Naitoh M; Yoshikawa K; Yamawaki S; Suzuki S; Hata R; Ueno S; Seki T; Kobayashi K; Toda T; Murakami K; Irie K; Klein WL; Mori H; Asada T; Takahashi R; Iwata N; Yamanaka S; Inoue H
Cell Stem Cell; 2013 Apr; 12(4):487-96. PubMed ID: 23434393
[TBL] [Abstract][Full Text] [Related]
38. SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease.
Brinkmalm A; Brinkmalm G; Honer WG; Frölich L; Hausner L; Minthon L; Hansson O; Wallin A; Zetterberg H; Blennow K; Öhrfelt A
Mol Neurodegener; 2014 Nov; 9():53. PubMed ID: 25418885
[TBL] [Abstract][Full Text] [Related]
39. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
Marei HE; Khan MUA; Hasan A
Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
[TBL] [Abstract][Full Text] [Related]
40. A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons.
Zhang D; Pekkanen-Mattila M; Shahsavani M; Falk A; Teixeira AI; Herland A
Biomaterials; 2014 Feb; 35(5):1420-8. PubMed ID: 24290439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
